Jane Street’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $301M | Sell |
10,730,000
-1,540,100
| -13% | -$41M | 0.04% | 292 |
|
|
2025
Q4 | $306M | Buy |
12,270,100
+5,765,000
| +89% | +$145M | 0.05% | 262 |
|
|
2025
Q3 | $166M | Sell |
6,505,100
-7,675,300
| -54% | -$189M | 0.03% | 402 |
|
|
2025
Q2 | $344M | Buy |
14,180,400
+3,608,800
| +34% | +$84.2M | 0.07% | 179 |
|
|
2025
Q1 | $268M | Buy |
10,571,600
+2,550,300
| +32% | +$66.7M | 0.07% | 169 |
|
|
2024
Q4 | $213M | Sell |
8,021,300
-730,400
| -8% | -$19.8M | 0.05% | 232 |
|
|
2024
Q3 | $253M | Buy |
8,751,700
+6,665,700
| +320% | +$194M | 0.06% | 182 |
|
|
2024
Q2 | $58.4M | Sell |
2,086,000
-1,380,500
| -40% | -$38M | 0.01% | 623 |
|
|
2024
Q1 | $96.2M | Sell |
3,466,500
-187,600
| -5% | -$5.21M | 0.02% | 377 |
|
|
2023
Q4 | $105M | Buy |
3,654,100
+431,500
| +13% | +$13M | 0.03% | 376 |
|
|
2023
Q3 | $107M | Sell |
3,222,600
-137,000
| -4% | -$4.84M | 0.03% | 301 |
|
|
2023
Q2 | $123M | Buy |
3,359,600
+462,100
| +16% | +$18M | 0.04% | 276 |
|
|
2023
Q1 | $118M | Sell |
2,897,500
-1,954,600
| -40% | -$84.4M | 0.05% | 259 |
|
|
2022
Q4 | $249M | Buy |
4,852,100
+580,600
| +14% | +$27.8M | 0.12% | 108 |
|
|
2022
Q3 | $187M | Sell |
4,271,500
-495,900
| -10% | -$24.1M | 0.08% | 138 |
|
|
2022
Q2 | $250M | Sell |
4,767,400
-1,582,900
| -25% | -$80.7M | 0.11% | 112 |
|
|
2022
Q1 | $329M | Sell |
6,350,300
-527,200
| -8% | -$27.4M | 0.11% | 100 |
|
|
2021
Q4 | $406M | Buy |
6,877,500
+1,537,300
| +29% | +$76.2M | 0.13% | 77 |
|
|
2021
Q3 | $230M | Buy |
5,340,200
+2,164,700
| +68% | +$95.9M | 0.08% | 138 |
|
|
2021
Q2 | $124M | Buy |
3,175,500
+1,065,100
| +50% | +$41.4M | 0.05% | 268 |
|
|
2021
Q1 | $76.5M | Sell |
2,110,400
-3,948,900
| -65% | -$140M | 0.04% | 352 |
|
|
2020
Q4 | $223M | Buy |
6,059,300
+2,406,347
| +66% | +$88.3M | 0.11% | 112 |
|
|
2020
Q3 | $127M | Buy |
3,652,953
+1,026,174
| +39% | +$36M | 0.08% | 168 |
|
|
2020
Q2 | $81.5M | Buy |
2,626,779
+462,074
| +21% | +$15.7M | 0.06% | 224 |
|
|
2020
Q1 | $67M | Buy |
2,164,705
+1,451,358
| +203% | +$49.5M | 0.07% | 199 |
|
|
2019
Q4 | $26.5M | Buy |
713,347
+112,145
| +19% | +$3.99M | 0.04% | 308 |
|
|
2019
Q3 | $20.5M | Buy |
601,202
+91,488
| +18% | +$3.33M | 0.03% | 352 |
|
|
2019
Q2 | $20.9M | Buy |
509,714
+44,268
| +10% | +$1.76M | 0.04% | 356 |
|
|
2019
Q1 | $18.8M | Sell |
465,446
-247,690
| -35% | -$9.92M | 0.03% | 430 |
|
|
2018
Q4 | $29.5M | Buy |
713,136
+425,921
| +148% | +$17.7M | 0.06% | 216 |
|
|
2018
Q3 | $12M | Buy |
287,215
+100,025
| +53% | +$3.85M | 0.02% | 504 |
|
|
2018
Q2 | $6.44M | Buy |
187,190
+73,042
| +64% | +$2.5M | 0.02% | 857 |
|
|
2018
Q1 | $3.84M | Buy |
114,148
+27,509
| +32% | +$946K | 0.01% | 1191 |
|
|
2017
Q4 | $2.98M | Buy |
86,639
+68,616
| +381% | +$2.34M | 0.01% | 1228 |
|
|
2017
Q3 | $610K | Sell |
18,023
-148,404
| -89% | -$4.77M | ﹤0.01% | 2855 |
|
|
2017
Q2 | $5.3M | Buy |
166,427
+94,123
| +130% | +$2.97M | 0.02% | 742 |
|
|
2017
Q1 | $2.35M | Buy |
72,304
+37,417
| +107% | +$1.18M | 0.01% | 1230 |
|
|
2016
Q4 | $1.07M | Buy |
34,887
+19,920
| +133% | +$608K | ﹤0.01% | 1977 |
|
|
2016
Q3 | $481K | Sell |
14,967
-37,206
| -71% | -$1.24M | ﹤0.01% | 2814 |
|
|
2016
Q2 | $1.74M | Sell |
52,173
-164,740
| -76% | -$5.26M | 0.01% | 1413 |
|
|
2016
Q1 | $6.1M | Buy |
216,913
+143,765
| +197% | +$4.11M | 0.03% | 473 |
|
|
2015
Q4 | $2.24M | Sell |
73,148
-74,834
| -51% | -$2.35M | 0.01% | 967 |
|
|
2015
Q3 | $4.41M | Buy |
147,982
+108,141
| +271% | +$3.47M | 0.03% | 504 |
|
|
2015
Q2 | $1.27M | Buy |
39,841
+11,488
| +41% | +$374K | 0.01% | 1351 |
|
|
2015
Q1 | $936K | Buy |
+28,353
| New | +$901K | 0.01% | 1428 |
|
Other funds holding PFE
VCM
VPM
Jane Street's PFE Position: Q1 2026 in Review
Jane Street increased its Pfizer (PFE) stake by 200% in Q1 2026, buying an estimated $33.4M and bringing the position to 1,883,213 shares worth $52.9M. The position accounts for 0.01% of the portfolio, ranked #1020.
Jane Street first reported a position in PFE in Q2 2013 and has held it in 47 quarters since. The position peaked at $260M in Q2 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Jane Street held 1,883,213 shares of Pfizer worth $52.9M as of Q1 2026.
- Jane Street bought 1,255,392 Pfizer shares in Q1 2026, an estimated $33.4M.
- Pfizer made up 0.01% of Jane Street's portfolio in Q1 2026, its #1020 holding.
- Jane Street first reported a position in Pfizer in Q2 2013 and has held it in 47 quarters since.
- Jane Street's Pfizer position peaked at $260M in Q2 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.